Key facts
- Theta Neurotech’s last known valuation is $8.0M (Oct 2025).
- It has raised $1.9M; the latest was Early Stage VC ($1.0M) in Oct 2025.
- Notable investors include Matter (Consulting Services (B2B)), Band of Angels, Polsky Center for Entrepreneurship and Innovation at the University of Chicago, Nashville Entrepreneur Center, Health Engine Accelerator — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Theta Neurotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Theta Neurotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Theta Neurotech
Manufacture of a wearable electrophysiological monitoring patch intended to predict epileptic seizure onset. The company offers a wearable brain-computer interface that alerts with epilepsy of an impending seizure before it occurs and allows targeted medication deployment and hospitalization reduction, enabling users to provide preventative drug deployment and restore independent lifestyles.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2022
- Employees
- 5
- Website
- thetaneurotech.com/
- Ownership
- Privately Held (backing)
Theta Neurotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Theta Neurotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Theta Neurotech in its N-PORT filings yet. We sweep new filings monthly.